HEADER HYDROLASE/HYDROLASE INHIBITOR 17-OCT-22 8ETE TITLE BILE SALT HYDROLASE FROM B. LONGUM WITH COVALENT INHIBITOR BOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CONJUGATED BILE ACID HYDROLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BILE SALT HYDROLASE,BSH,CHENODEOXYCHOLOYLTAURINE HYDROLASE, COMPND 5 CHOLOYLGLYCINE HYDROLASE; COMPND 6 EC: 3.5.1.-,3.5.1.74,3.5.1.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BIFIDOBACTERIUM LONGUM; SOURCE 3 ORGANISM_TAXID: 216816; SOURCE 4 GENE: BSH; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BILE SALT HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.E.WALKER,M.R.REDINBO REVDAT 1 01-NOV-23 8ETE 0 JRNL AUTH M.E.WALKER,M.R.REDINBO JRNL TITL STRUCTURAL DIVERSITY OF BILE SALT HYDROLASES REVEALS JRNL TITL 2 RATIONALE FOR SUBSTRATE SELECTIVITY JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20_4459 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.89 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 42255 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.770 REMARK 3 FREE R VALUE TEST SET COUNT : 2015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.8900 - 5.5400 1.00 3132 157 0.1861 0.2271 REMARK 3 2 5.5400 - 4.4000 1.00 2996 149 0.1840 0.2047 REMARK 3 3 4.4000 - 3.8400 1.00 2973 145 0.2106 0.2373 REMARK 3 4 3.8400 - 3.4900 1.00 2956 147 0.2383 0.2852 REMARK 3 5 3.4900 - 3.2400 1.00 2916 145 0.2716 0.3065 REMARK 3 6 3.2400 - 3.0500 1.00 2926 150 0.3049 0.3373 REMARK 3 7 3.0500 - 2.9000 1.00 2931 143 0.3235 0.3283 REMARK 3 8 2.9000 - 2.7700 1.00 2911 147 0.3592 0.4279 REMARK 3 9 2.7700 - 2.6700 1.00 2882 142 0.3893 0.4310 REMARK 3 10 2.6600 - 2.5700 1.00 2896 147 0.4056 0.3691 REMARK 3 11 2.5700 - 2.4900 0.99 2894 148 0.4188 0.4480 REMARK 3 12 2.4900 - 2.4200 0.97 2818 139 0.4446 0.4258 REMARK 3 13 2.4200 - 2.3600 0.90 2604 136 0.4826 0.5297 REMARK 3 14 2.3600 - 2.3000 0.84 2405 120 0.5106 0.5789 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.528 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 40.918 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 60.28 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4916 REMARK 3 ANGLE : 0.550 6714 REMARK 3 CHIRALITY : 0.044 732 REMARK 3 PLANARITY : 0.003 874 REMARK 3 DIHEDRAL : 5.948 724 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8ETE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1000269342. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43164 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.890 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 10.40 REMARK 200 R MERGE (I) : 0.32540 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.7 REMARK 200 DATA REDUNDANCY IN SHELL : 10.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2HF0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE, 0.1 M HEPES:NAOH REMARK 280 PH 7.5, 25% (W/V) PEG4000, 0.2 M LITHIUM SULFATE. PROTEIN REMARK 280 CRYSTALLIZED IN A 1:2 PROTEIN:CRYSTALLANT RATIO. PROTEIN WAS REMARK 280 INCUBATED WITH INHIBITOR PRIOR TO TRAY SETUP AND WAS 8.55 MG/ML REMARK 280 FINAL CONCENTRATION., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 110.12467 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.06233 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 55.06233 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 110.12467 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -101.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 55.06233 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ILE A 132 REMARK 465 VAL A 133 REMARK 465 PRO A 134 REMARK 465 GLY A 135 REMARK 465 GLN A 136 REMARK 465 ARG A 317 REMARK 465 MET B 1 REMARK 465 ARG B 317 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 10 CG OD1 OD2 REMARK 470 SER A 25 OG REMARK 470 GLU A 28 CG CD OE1 OE2 REMARK 470 LEU A 31 CG CD1 CD2 REMARK 470 LYS A 50 CG CD CE NZ REMARK 470 GLU A 92 CG CD OE1 OE2 REMARK 470 GLU A 95 CG CD OE1 OE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 GLU A 104 CG CD OE1 OE2 REMARK 470 GLU A 121 CG CD OE1 OE2 REMARK 470 ARG A 124 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 131 CG CD OE1 NE2 REMARK 470 GLN A 137 CG CD OE1 NE2 REMARK 470 GLU A 155 CG CD OE1 OE2 REMARK 470 ASP A 159 CG OD1 OD2 REMARK 470 ASP A 178 CG OD1 OD2 REMARK 470 ARG A 298 CG CD NE CZ NH1 NH2 REMARK 470 SER A 309 OG REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 ASP B 10 CG OD1 OD2 REMARK 470 GLU B 11 CG CD OE1 OE2 REMARK 470 GLU B 28 CG CD OE1 OE2 REMARK 470 ASP B 40 CG OD1 OD2 REMARK 470 LYS B 50 CG CD CE NZ REMARK 470 ASP B 63 CG OD1 OD2 REMARK 470 ASP B 69 CG OD1 OD2 REMARK 470 GLU B 95 CG CD OE1 OE2 REMARK 470 GLU B 104 CG CD OE1 OE2 REMARK 470 GLU B 138 CG CD OE1 OE2 REMARK 470 LYS B 149 CG CD CE NZ REMARK 470 ASP B 178 CG OD1 OD2 REMARK 470 GLU B 196 CG CD OE1 OE2 REMARK 470 LYS B 202 CG CD CE NZ REMARK 470 GLN B 239 CG CD OE1 NE2 REMARK 470 ASN B 241 CG OD1 ND2 REMARK 470 ASP B 242 CG OD1 OD2 REMARK 470 LYS B 283 CG CD CE NZ REMARK 470 ASP B 306 CG OD1 OD2 REMARK 470 ILE B 313 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 9 -153.89 -93.45 REMARK 500 VAL A 60 68.35 -119.40 REMARK 500 ALA A 62 -110.38 54.31 REMARK 500 TYR A 86 -37.25 -131.33 REMARK 500 ASP A 147 -139.88 -129.05 REMARK 500 LYS A 149 -53.55 -122.36 REMARK 500 ASN A 173 -147.22 -62.72 REMARK 500 PRO A 175 -146.87 -87.00 REMARK 500 MET A 266 -165.32 -102.75 REMARK 500 THR A 274 94.45 -65.39 REMARK 500 SER A 309 -179.99 -69.31 REMARK 500 ASP B 9 -158.89 -94.21 REMARK 500 PHE B 83 46.37 -143.95 REMARK 500 TYR B 86 -40.43 -131.61 REMARK 500 ASP B 147 -153.53 -133.45 REMARK 500 THR B 172 -156.76 -126.40 REMARK 500 ASN B 173 -139.63 -87.17 REMARK 500 PRO B 175 -147.34 -89.14 REMARK 500 THR B 274 91.86 -64.20 REMARK 500 ASP B 306 96.08 -68.10 REMARK 500 REMARK 500 REMARK: NULL DBREF 8ETE A 1 317 UNP Q9KK62 CBH_BIFLN 1 317 DBREF 8ETE B 1 317 UNP Q9KK62 CBH_BIFLN 1 317 SEQRES 1 A 317 MET CYS THR GLY VAL ARG PHE SER ASP ASP GLU GLY ASN SEQRES 2 A 317 THR TYR PHE GLY ARG ASN LEU ASP TRP SER PHE SER TYR SEQRES 3 A 317 GLY GLU THR ILE LEU VAL THR PRO ARG GLY TYR HIS TYR SEQRES 4 A 317 ASP THR VAL PHE GLY ALA GLY GLY LYS ALA LYS PRO ASN SEQRES 5 A 317 ALA VAL ILE GLY VAL GLY VAL VAL MET ALA ASP ARG PRO SEQRES 6 A 317 MET TYR PHE ASP CYS ALA ASN GLU HIS GLY LEU ALA ILE SEQRES 7 A 317 ALA GLY LEU ASN PHE PRO GLY TYR ALA SER PHE VAL HIS SEQRES 8 A 317 GLU PRO VAL GLU GLY THR GLU ASN VAL ALA THR PHE GLU SEQRES 9 A 317 PHE PRO LEU TRP VAL ALA ARG ASN PHE ASP SER VAL ASP SEQRES 10 A 317 GLU VAL GLU GLU THR LEU ARG ASN VAL THR LEU VAL SER SEQRES 11 A 317 GLN ILE VAL PRO GLY GLN GLN GLU SER LEU LEU HIS TRP SEQRES 12 A 317 PHE ILE GLY ASP GLY LYS ARG SER ILE VAL VAL GLU GLN SEQRES 13 A 317 MET ALA ASP GLY MET HIS VAL HIS HIS ASP ASP VAL ASP SEQRES 14 A 317 VAL LEU THR ASN GLN PRO THR PHE ASP PHE HIS MET GLU SEQRES 15 A 317 ASN LEU ARG ASN TYR MET CYS VAL SER ASN GLU MET ALA SEQRES 16 A 317 GLU PRO THR SER TRP GLY LYS ALA SER LEU THR ALA TRP SEQRES 17 A 317 GLY ALA GLY VAL GLY MET HIS GLY ILE PRO GLY ASP VAL SEQRES 18 A 317 SER SER PRO SER ARG PHE VAL ARG VAL ALA TYR THR ASN SEQRES 19 A 317 ALA HIS TYR PRO GLN GLN ASN ASP GLU ALA ALA ASN VAL SEQRES 20 A 317 SER ARG LEU PHE HIS THR LEU GLY SER VAL GLN MET VAL SEQRES 21 A 317 ASP GLY MET ALA LYS MET GLY ASP GLY GLN PHE GLU ARG SEQRES 22 A 317 THR LEU PHE THR SER GLY TYR SER SER LYS THR ASN THR SEQRES 23 A 317 TYR TYR MET ASN THR TYR ASP ASP PRO ALA ILE ARG SER SEQRES 24 A 317 TYR ALA MET ALA ASP TYR ASP MET ASP SER SER GLU LEU SEQRES 25 A 317 ILE SER VAL ALA ARG SEQRES 1 B 317 MET CYS THR GLY VAL ARG PHE SER ASP ASP GLU GLY ASN SEQRES 2 B 317 THR TYR PHE GLY ARG ASN LEU ASP TRP SER PHE SER TYR SEQRES 3 B 317 GLY GLU THR ILE LEU VAL THR PRO ARG GLY TYR HIS TYR SEQRES 4 B 317 ASP THR VAL PHE GLY ALA GLY GLY LYS ALA LYS PRO ASN SEQRES 5 B 317 ALA VAL ILE GLY VAL GLY VAL VAL MET ALA ASP ARG PRO SEQRES 6 B 317 MET TYR PHE ASP CYS ALA ASN GLU HIS GLY LEU ALA ILE SEQRES 7 B 317 ALA GLY LEU ASN PHE PRO GLY TYR ALA SER PHE VAL HIS SEQRES 8 B 317 GLU PRO VAL GLU GLY THR GLU ASN VAL ALA THR PHE GLU SEQRES 9 B 317 PHE PRO LEU TRP VAL ALA ARG ASN PHE ASP SER VAL ASP SEQRES 10 B 317 GLU VAL GLU GLU THR LEU ARG ASN VAL THR LEU VAL SER SEQRES 11 B 317 GLN ILE VAL PRO GLY GLN GLN GLU SER LEU LEU HIS TRP SEQRES 12 B 317 PHE ILE GLY ASP GLY LYS ARG SER ILE VAL VAL GLU GLN SEQRES 13 B 317 MET ALA ASP GLY MET HIS VAL HIS HIS ASP ASP VAL ASP SEQRES 14 B 317 VAL LEU THR ASN GLN PRO THR PHE ASP PHE HIS MET GLU SEQRES 15 B 317 ASN LEU ARG ASN TYR MET CYS VAL SER ASN GLU MET ALA SEQRES 16 B 317 GLU PRO THR SER TRP GLY LYS ALA SER LEU THR ALA TRP SEQRES 17 B 317 GLY ALA GLY VAL GLY MET HIS GLY ILE PRO GLY ASP VAL SEQRES 18 B 317 SER SER PRO SER ARG PHE VAL ARG VAL ALA TYR THR ASN SEQRES 19 B 317 ALA HIS TYR PRO GLN GLN ASN ASP GLU ALA ALA ASN VAL SEQRES 20 B 317 SER ARG LEU PHE HIS THR LEU GLY SER VAL GLN MET VAL SEQRES 21 B 317 ASP GLY MET ALA LYS MET GLY ASP GLY GLN PHE GLU ARG SEQRES 22 B 317 THR LEU PHE THR SER GLY TYR SER SER LYS THR ASN THR SEQRES 23 B 317 TYR TYR MET ASN THR TYR ASP ASP PRO ALA ILE ARG SER SEQRES 24 B 317 TYR ALA MET ALA ASP TYR ASP MET ASP SER SER GLU LEU SEQRES 25 B 317 ILE SER VAL ALA ARG HET WU5 A 401 27 HET WU5 B 401 27 HETNAM WU5 (5R)-1-FLUORO-5-[(1R,3AS,3BR,5AR,7R,9AS,9BS,11AR)-7- HETNAM 2 WU5 HYDROXY-9A,11A-DIMETHYLHEXADECAHYDRO-1H- HETNAM 3 WU5 CYCLOPENTA[A]PHENANTHREN-1-YL]HEXAN-2-ONE (NON- HETNAM 4 WU5 PREFERRED NAME) FORMUL 3 WU5 2(C25 H41 F O2) HELIX 1 AA1 GLU A 104 PHE A 113 1 10 HELIX 2 AA2 SER A 115 LEU A 123 1 9 HELIX 3 AA3 THR A 176 ARG A 185 1 10 HELIX 4 AA4 ASN A 186 MET A 188 5 3 HELIX 5 AA5 GLY A 211 HIS A 215 5 5 HELIX 6 AA6 SER A 222 TYR A 237 1 16 HELIX 7 AA7 ASP A 242 SER A 256 1 15 HELIX 8 AA8 ALA A 303 TYR A 305 5 3 HELIX 9 AA9 GLU B 104 PHE B 113 1 10 HELIX 10 AB1 SER B 115 LEU B 123 1 9 HELIX 11 AB2 THR B 176 LEU B 184 1 9 HELIX 12 AB3 ARG B 185 MET B 188 5 4 HELIX 13 AB4 GLY B 211 HIS B 215 5 5 HELIX 14 AB5 SER B 222 TYR B 237 1 16 HELIX 15 AB6 ASP B 242 SER B 256 1 15 HELIX 16 AB7 ALA B 303 TYR B 305 5 3 SHEET 1 AA1 6 VAL A 170 THR A 172 0 SHEET 2 AA1 6 THR A 3 SER A 8 -1 N GLY A 4 O LEU A 171 SHEET 3 AA1 6 THR A 14 TRP A 22 -1 O GLY A 17 N VAL A 5 SHEET 4 AA1 6 ARG A 273 SER A 281 -1 O SER A 278 N ARG A 18 SHEET 5 AA1 6 THR A 286 THR A 291 -1 O TYR A 288 N GLY A 279 SHEET 6 AA1 6 ASP A 294 ALA A 301 -1 O TYR A 300 N TYR A 287 SHEET 1 AA2 8 GLY A 160 HIS A 165 0 SHEET 2 AA2 8 SER A 151 MET A 157 -1 N GLU A 155 O HIS A 162 SHEET 3 AA2 8 LEU A 141 GLY A 146 -1 N ILE A 145 O ILE A 152 SHEET 4 AA2 8 ALA A 77 ASN A 82 -1 N ALA A 79 O PHE A 144 SHEET 5 AA2 8 ARG A 64 ASN A 72 -1 N CYS A 70 O ILE A 78 SHEET 6 AA2 8 VAL A 54 MET A 61 -1 N ILE A 55 O ALA A 71 SHEET 7 AA2 8 THR A 29 THR A 33 -1 N THR A 29 O GLY A 58 SHEET 8 AA2 8 ILE A 313 VAL A 315 -1 O ILE A 313 N VAL A 32 SHEET 1 AA3 2 GLU A 98 ALA A 101 0 SHEET 2 AA3 2 VAL A 126 VAL A 129 1 O THR A 127 N VAL A 100 SHEET 1 AA4 2 THR A 198 TRP A 200 0 SHEET 2 AA4 2 ALA A 203 LEU A 205 -1 O LEU A 205 N THR A 198 SHEET 1 AA5 6 VAL B 170 LEU B 171 0 SHEET 2 AA5 6 THR B 3 PHE B 7 -1 N GLY B 4 O LEU B 171 SHEET 3 AA5 6 TYR B 15 TRP B 22 -1 O GLY B 17 N VAL B 5 SHEET 4 AA5 6 ARG B 273 SER B 281 -1 O TYR B 280 N PHE B 16 SHEET 5 AA5 6 THR B 286 THR B 291 -1 O TYR B 288 N GLY B 279 SHEET 6 AA5 6 ASP B 294 ALA B 301 -1 O TYR B 300 N TYR B 287 SHEET 1 AA6 8 GLY B 160 ASP B 166 0 SHEET 2 AA6 8 SER B 151 MET B 157 -1 N GLU B 155 O HIS B 162 SHEET 3 AA6 8 LEU B 141 GLY B 146 -1 N ILE B 145 O ILE B 152 SHEET 4 AA6 8 ALA B 77 ASN B 82 -1 N LEU B 81 O HIS B 142 SHEET 5 AA6 8 ARG B 64 ASN B 72 -1 N PHE B 68 O GLY B 80 SHEET 6 AA6 8 VAL B 54 MET B 61 -1 N ILE B 55 O ALA B 71 SHEET 7 AA6 8 THR B 29 THR B 33 -1 N LEU B 31 O GLY B 56 SHEET 8 AA6 8 ILE B 313 VAL B 315 -1 O ILE B 313 N VAL B 32 SHEET 1 AA7 2 GLU B 98 ALA B 101 0 SHEET 2 AA7 2 VAL B 126 VAL B 129 1 O THR B 127 N GLU B 98 SHEET 1 AA8 2 THR B 198 TRP B 200 0 SHEET 2 AA8 2 ALA B 203 LEU B 205 -1 O ALA B 203 N TRP B 200 LINK SG CYS A 2 C1 WU5 A 401 1555 1555 1.77 LINK SG CYS B 2 C1 WU5 B 401 1555 1555 1.76 CISPEP 1 GLN A 174 PRO A 175 0 -0.72 CISPEP 2 GLN B 174 PRO B 175 0 -5.45 CRYST1 100.085 100.085 165.187 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009992 0.005769 0.000000 0.00000 SCALE2 0.000000 0.011537 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006054 0.00000